News Releases

Experienced global healthcare leader to accelerate innovation and expand its impact for laboratories, clinicians and patients. BREA, Calif., Oct. 14, 2026 /PRNewswire/ -- Beckman Coulter...

The DxU 1800 System features new urine chemistry analyzer and consumables with market-leading microscopy helping laboratories to meet rising diagnostic demand BREA, Calif., July 23, 2026...

CE-marked Access p-Tau217 blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of cognitive decline across Europe Brain Derived pTau217 RUO...

Modeling Shows Adoption of New Access MeMed BV Assay Could Cut up to €80M in Avoidable Costs across European Health Systems through Fewer Unnecessary Admissions and Testing BREA, Calif., April...

Beckman Coulter Also Announces Development of Aß-42 Research Use Only Immunoassay Test BREA, Calif., Sept. 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a Danaher company and a leader in...

The new DxC 500i Analyzer Offers Flexibility and Scalability with Broad Chemistry and Immunoassay Assay Menu BREA, Calif., March 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical...

Beckman Coulter Diagnostics, a global leader in clinical diagnostics, today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Beckman Coulter's...

New, Fully Automated, High-Throughput RUO Assays offered on Beckman Coulter Immunoassay Analyzers BREA, Calif., Jan. 15, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in...

Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, today jointly announced expansion of its long-term...

The collaboration aims to identify and develop accessible, minimally invasive blood-based biomarkers specific for tau pathology in the brain. These tools have the potential to be used to...

Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the DxI 9000 Immunoassay Analyzer* was honored during Premier, Inc.'s annual supplier Innovation Celebration at its...

Ideally Suited for Satellite and Independent Labs, the new DxC 500i Analyzer Offers Flexibility, Scalability and Data Commutability with Extensive Chemistry and Immunoassay Assay Menu The New DxC...

New Access NT-proBNP Assay Detects Heart Failure Biomarker in Less than 11 Minutes Patient Results Evaluated Within Context of Clinically Relevant Age-Based Cutoffs, Disease Comorbidity Data and...

Beckman Coulter Now an Authorized Distributor of MeMed Key Immunoassay System and MeMed BV Assay Progress Continues on Original Collaboration to Develop a MeMed BV-Based Assay for use on Beckman...

Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global), that...

Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manufacturing, today announced an expansion of their...

Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced Kevin O'Reilly's appointment as its new president succeeding Julie Sawyer Montgomery, who is now vice president and...

New analyzer complements hub labs by advancing capabilities of satellite and independent community hospital labs DUBAI , UAE, Jan. 29, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical...

Beckman Coulter, a clinical diagnostics leader, today revealed for the first time in North America the DxI 9000 Access Immunoassay Analyzer, addressing clinical laboratory demands for speed,...

Beckman Coulter Diagnostics, a clinical diagnostics leader, received FDA clearance for its new DxC 500 AU Chemistry Analyzer, an automated chemistry analyzer, expanding the company's clinical...

Connecting the DxH 900 Workcell and DxH Slidemaker Stainer II with the Scopio X100HT High-throughput Digital Cell Morphology Platform Improves Lab Efficiency by Automating Hematology Workflow By...

Collaboration Builds upon Fujirebio Expertise in Neurodegenerative Disease Assays and Beckman Coulter's High Sensitivity, High Throughput, Global Installed Base of Access Family of Immunoassay...

DxI 9000 Access Immunoassay Analyzer Boasts Industry's Highest Throughput per Footprint: Up To 215 Tests/Hour/Square Meter Innovations Bolster Assay Performance and Laboratory Productivity with...

Collaboration to Add MeMed BV to Beckman Coulter Test Menu for use on Access Family of Immunoassay Analyzers BREA, Calif. and HAIFA, Israel , Jan. 31, 2023 /PRNewswire/ -- Beckman Coulter...

StoCastic's TriageGo, a triage decision support tool that integrates electronic health records and emergency department workflows, will be a cornerstone of Beckman Coulter's Clinical Decision...

Beckman Coulter, global leader in advanced diagnostics, today announced that it will partner with Massachusetts General Hospital to validate the use of the novel Monocyte Distribution Width (MDW)...

Beckman Coulter, a global leader in clinical diagnostics, and Scopio Labs, a medtech company that develops AI-powered workflow solutions, announced today a worldwide partnership to accelerate...

Beckman Coulter, a global clinical diagnostics leader, announces a new partnership with Germany-based company Smart4Diagnostics to close the preanalytical data gap between blood collection and...

Global distribution agreement with Saladax Biomedical brings antipsychotic therapeutic drug monitoring assays to Beckman Coulter customers BREA, Calif. , March 15, 2022 /PRNewswire/ -- Beckman...

Beckman Coulter today announced the launch of its DxU Iris Workcell at the AACC Annual Scientific Meeting & Clinical Lab Expo. The DxU Iris Workcell is a fully automated system that streamlines...

Beckman Coulter, a global clinical diagnostics leader, today announced that it has entered into definitive agreements with Quidel Corporation to obtain all rights related to the manufacture,...

Beckman Coulter, a global clinical diagnostics leader, today announced the launch of Access SARS-CoV-2 IgG (1st IS), a fully-quantitative lab-based Immunoglobulin G (IgG) serology test that...

Beckman Coulter, a clinical diagnostics leader, today announced the global launch of the DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized labs that run fewer than...

Beckman Coulter, a clinical diagnostics leader, today announced that its Access SARS-CoV-2 IgG II antibody assay received U.S. Emergency Use Authorization (EUA) from the U.S. Food and Drug...

Beckman Coulter, a clinical diagnostics leader, today announced their commitment to support the U.S. government's plan to invest more than $12 billion to expand COVID-19 testing with their...

Beckman Coulter, a global leader in clinical diagnostics, announced today the launch of the DxH 560 AL, a tabletop analyzer geared to reduce the time and resource constraints faced by small to...

Below is the updated press release. Beckman Coulter Launches one of the First High-Quality, High-Throughput COVID-19 Antigen Test Ideal for Mass Testing in the U.S. The Access SARS-CoV-2 Antigen...

Beckman Coulter, a clinical diagnostics leader, today launched its Access SARS-CoV-2 IgG II assay that measures a patient's relative level of antibodies in response to a previous SARS-CoV-2...

Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The new IgM antibody test...

Beckman Coulter, a global clinical diagnostics leader, today announced that it was awarded funding by the Biomedical Advanced Research and Development Authority (BARDA) part of the office of the...

Beckman Coulter, a clinical diagnostics leader, today announced its Access SARS-CoV-2 Immunoglobulin M (IgM) assay has received Emergency Use Authorization (EUA) from the U.S. Food and Drug...

Beckman Coulter, a clinical diagnostics leader, today announced research results that demonstrate its Access SARS-CoV-2 IgG assay shows excellent agreement to the Genscript SARS-CoV-2 Surrogate...

Beckman Coulter today announced that it has received Emergency Use Authorization (EUA) for its Access Interleukin-6 (IL-6) assay from the U.S. Food & Drug Administration (FDA). Access IL-6 is a...

Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay. The new IgM antibody test demonstrated 99.9% specificity against...

Beckman Coulter today announced new analysis from the pivotal study of its novel monocyte distribution width (MDW) hematologic biomarker for sepsis detection. The analysis showed that abnormal MDW...

Beckman Coulter today announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its PK7400 Automated Microplate System and the system's reagents have...

Beckman Coulter, a global leader in clinical diagnostics, announced today that it received the Scientists' Choice Award® for Best New Clinical Laboratory Instrumentation of 2019 for its DxA 5000...

Beckman Coulter today announced that it received nine Clinical Laboratory Awards from IMV across five separate categories. The company's Immunoassay, Integrated Systems and Urinalysis instruments...

Beckman Coulter and Lenco Diagnostic Laboratories (Lenco), one of NYC's largest privately-owned full-service reference laboratories, today announced that the first shipment of 40,000 of Beckman...

Beckman Coulter today announced that its Access SARS-CoV-2 IgG assay has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA). Beckman Coulter has already...

Brea, Calif, June 15, 2020 — Beckman Coulter today announced that its Access SARS-CoV-2 IgG assay is now available in markets accepting the CE Mark. The company has already shipped tests to more...

Beckman Coulter announced today the availability of its DxH 690T hematology analyzer in the U.S. Designed to streamline workflow and minimize downtime in mid-volume laboratories, the DxH 690T...

Beckman Coulter today announced it was awarded an expanded partnership with BARDA as part of their rapidly expanding COVID-19 medical countermeasure portfolio. The partnership was awarded to...

Building on its strong commitment to the fight against coronavirus (COVID-19), Beckman Coulter today announced a mid-May launch timeline for its new Access SARS-CoV-2 IgG serology test and plans...

In response to the global COVID-19 pandemic, Beckman Coulter today announced that it is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2. The assays will be...

Beckman Coulter, a global leader in clinical diagnostics, today announced that its Access PCT assay has received FDA 510(k) clearance and is now available for sale in the United States. The...

Beckman Coulter, a global leader in clinical diagnostics, announced today that South West London Pathology (SWLP) has implemented DxH 900 haematology analysers and the Early Sepsis Indicator...

Beckman Coulter, Inc., a Danaher company, today announced that it has initially been awarded a contract of $1.25 million, with potential to be awarded an additional $6.5 million if all contract...

Designed for mid-volume laboratories, Beckman Coulter’s DxH 690T offers industry-leading 93% first pass yield, and includes a 5-part differential and the Early Sepsis Indicator Brea, Calif., Oct...

Beckman Coulter, a global leader in clinical diagnostics, announced today that the DxA 5000 total laboratory automation solution has received FDA 510(k) clearance and is now available for sale in...

Beckman Coulter, a global leader in clinical diagnostics, announced today that its small, but mighty DxH 520 hematology analyzer received the Scientists' Choice Award® for Best New Clinical...

Beckman Coulter announced that its MicroScan WalkAway family of instruments has once again received IMV ServiceTrak's "Best System Performance" award in the AST/ID category. ServiceTrak™...

Beckman Coulter today announced that at the 71st Annual AACC conference it will showcase its clinical chemistry, immunoassay, hematology, urinalysis and microbiology solutions, configured in the...

The DxA 5000 delivers rapid and consistent turnaround time, provides the industry’s most comprehensive pre-analytical sample quality assessment and improves laboratory efficiency BREA, Calif....

A major milestone on its strategic mission to lead in sepsis diagnostics, Beckman Coulter today announced that its Early Sepsis Indicator has received 510(k) clearance from the U.S. Food and Drug...

Access PCT strengthens industry’s most extensive portfolio of in-vitro diagnostic testing for sepsis identification and management BREA, Calif. — (March 26, 2019) — Beckman Coulter, a global...

Beckman Coulter, a global leader in clinical diagnostics, announced today that its DxH 520 hematology analyzer has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), and...

Beckman Coulter, a global leader in the clinical diagnostics industry, today announced the latest addition to its comprehensive chemistry assay menu—the fully automated hemoglobin A1c (HbA1c)...

Beckman Coulter today announced the U.S. release of its DxONE Workflow Manager, the first and only cloud-based middleware offered by a major in-vitro diagnostics organization, designed to help...

Beckman Coulter, a global leader in the clinical diagnostics industry, today announced it is joining forces with Sepsis Alliance, the nation's leading sepsis organization, to support the Sepsis...

Beckman Coulter announced today commercialization of DxONE Inventory Manager, its automated, cloud-based software technology that simplifies inventory management and enhances operational...

Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry, is embarking on an innovation collaboration with Johns Hopkins Medicine to explore co-innovation initiatives with...

Featuring innovative technology, these diagnostic tools will help enhance analysis and detection for critical blood-based conditions and diseases for patients across the country BREA, Calif.,...

Beckman Coulter today announced the release of its newest software version for the company's flagship middleware system, REMISOL Advance. The software iteration features enhancements—designed in...

Beckman Coulter, a global leader in the clinical diagnostics industry, announced today that it is a gold sponsor of the 2nd World Sepsis Congress, a free-of-charge online conference, hosted by the...

Beckman Coulter announced today commercialization of its DxM MicroScan WalkAway system, a diagnostic solution for bacterial identification and antibiotic susceptibility testing for microbiology...

Beckman Coulter and U.S. ARKRAY, Inc. (ARKRAY) announced a new partnership and the launch of the iQ Urinalysis Workcell. The iQ Workcell pairs two of the world's most highly regarded automated...

Beckman Coulter Diagnostics goes beyond technology to help laboratories face challenges in the current healthcare environment BREA, Calif. — (July 20, 2018) — Beckman Coulter, a global leader...

Beckman Coulter Diagnostics announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new high-sensitivity troponin (hsTnI) assay, Access hsTnI, for...

New assay enables hospitals to provide efficiency improvements in cardiac patient management BREA, Calif. — (June 26, 2018) — Beckman Coulter Diagnostics announced today that it has received...

Beckman Coulter announced that it has filed a submission for 510(k) clearance with the U.S. Food and Drug Administration (FDA) for its Early Sepsis Indicator. The first-of-its-kind...

Agreement to focus on accelerating campus innovation from lab to real world via UCI Applied Innovation IRVINE, Calif. — (June 21, 2018) — Beckman Coulter Diagnostics, a global leader in the...

The new Access Sensitive Estradiol assay completes the comprehensive reproductive menu for Access immunoassay systems and provides better operational efficiency while delivering quality results....

Beckman Coulter announced today the positive results of a clinical trial suggesting that blood tests may offer key benefits in the initial screening for obstructive sleep apnea. The study, which...

Software version 2 enhancements improve flagging and streamline the quality control processes BREA, Calif. — (May 10, 2018) — Beckman Coulter Diagnostics announced today the global launch of...

First-of-its-kind hematology-based test intended to alert emergency department clinicians to the possibility of sepsis or risk of developing sepsis as part of a routine CBC with differential test...

Beckman Coulter announced today the release of the DxH 900 hematology analyzer, giving mid- to high-volume clinical laboratories the ability to perform complete blood count and white blood cell...

BREA, Calif. — (April 18, 2018) — Beckman Coulter Diagnostics announced achievement of CE Mark of its DxH 520 hematology analyzer, designed to help physician office laboratories deliver...

Beckman Coulter, a global leader in the clinical diagnostics industry, today announced its exclusive sponsorship of the ESCAVO Sepsis Clinical Guide (Sepsis app), a point-of-care medical reference...

Beckman Coulter Diagnostics today announced commercialization of its Access Sensitive Estradiol in the U.S., with simultaneous commercial availability of its assay in the majority of global...

BALLINA, Co. Tipperary (Ireland) and BREA, Calif. (USA) – (March 15, 2018) — Long-term agreement expands Beckman Coulter customers’ access to high-quality QC products, supporting efficient...

Fully contained automation solution boosts laboratory productivity, workflow flexibility and testing quality BREA, Calif. — (Feb. 20 2018) — Beckman Coulter Diagnostics and NTE-SENER, the...

Beckman Coulter Diagnostics today announced the addition of 6-Acetylmorphine (6-AM) and Buprenorphine (BUP) assays to its broad menu of drugs-of-abuse tests that meet the demands of onsite testing...

Beckman Coulter Diagnostics announced FDA clearance of its automated Access AMH immunoassay for in vitro diagnostic (IVD) use in the U.S. This simple test aids healthcare providers in the...

Beckman Coulter is committed to ensuring customers receive the highest quality assays, on-time, to help healthcare and laboratory professionals provide better patient care. To further these goals,...

A study published in Prostate Cancer and Prostatic Diseases demonstrated that physicians elected to perform fewer biopsies when phi testing was included in their overall, routine, clinical assessment.

New assay enables hospitals to provide efficiency improvements in cardiac patient management BREA, Calif. —(Nov. 7, 2017) — Beckman Coulter Diagnostics announced today that it has received CE...

Beckman Coulter Diagnostics is pleased to announce worldwide availability of the Access 2 immunoassay system with enhanced features. Built upon a 20-year legacy of reliable and efficient...

Beckman Coulter Diagnostics introduces its DxONE information management solutions, an integrated system of technologies and capabilities, designed to ease data access and usability. DxONE is...

Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry will present its global initiative, "Partnering Today for a Stronger Tomorrow," at the 69th American Association...